Connection

Michelle Willicombe to Immunosuppressive Agents

Back to Details
This is a "connection" page, showing publications Michelle Willicombe has written about Immunosuppressive Agents.
Michelle Willicombe
Connection Strength
0.369
Immunosuppressive Agents
  1. COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm? J Am Soc Nephrol. 2020 Jun; 31(6):1145-1146.
    View in: PubMed
    Score: 0.224
  2. COVID-19 Reinfection in a Patient Receiving Immunosuppressive Treatment for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2021 06; 73(6):1091-1092.
    View in: PubMed
    Score: 0.060
  3. Identification of Patient Characteristics Associated With SARS-CoV-2 Infection and Outcome in Kidney Transplant Patients Using Serological Screening. Transplantation. 2021 01 01; 105(1):151-157.
    View in: PubMed
    Score: 0.059
  4. Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression. Ann Rheum Dis. 2021 10; 80(10):1322-1329.
    View in: PubMed
    Score: 0.015
  5. Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy. Kidney Int. 2017 10; 92(4):942-952.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.